Polymer particles containing Fe-based metalloporphyrin as a highly efficient stimulator of reactive oxygen species formation in vitro and in vivo


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Reactive oxygen species are generated by the redox reaction involving metalloporphyrin and ascorbic acid (AA) and lead to oxidative stress followed by cancer cell death. Polymer particles based on the copolymer of lactic and glycolic acid (PLGA) containing FeIIICl-tetraphenylporphyrin (FeClTPP) were prepared and characterized. These particles in combination with AA exhibit cytotoxic activity against the K562 (human chronic myelogenous leukemia) and MCF7 (human breast adenocarcinoma) cell lines. Results in vitro indicated significant antitumor efficiency on mice inoculated with P388 leukemic cells and treated with FeClTPP/AA. The cytotoxic activity of the combined system is achieved due to the formation of reactive oxygen species. The application of this system to the study of anticancer efficiency in vivo on the model of mice that were hypodermically inoculated with P388 lymphocytic leukemia revealed a significant inhibition of tumor growth. The use of FeClTPP in combination with AA seems to be promising in cancer treatment.

Об авторах

M. Faustova

Russian Research Center for Molecular Diagnostics and Therapy; MIREA — Russian Technological University, Institute of Fine Chemical Technologies

Автор, ответственный за переписку.
Email: phaustova112@yandex.ru
Россия, 8 Simferopol’sky bulv., Moscow, 117638; 78 prosp. Vernadskogo, Moscow, 119454

E. Nikolskaya

Russian Research Center for Molecular Diagnostics and Therapy; N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: phaustova112@yandex.ru
Россия, 8 Simferopol’sky bulv., Moscow, 117638; 4 ul. Kosygina, Moscow, 119991

M. Mollaev

MIREA — Russian Technological University, Institute of Fine Chemical Technologies

Email: phaustova112@yandex.ru
Россия, 78 prosp. Vernadskogo, Moscow, 119454

M. Sokol

Russian Research Center for Molecular Diagnostics and Therapy

Email: phaustova112@yandex.ru
Россия, 8 Simferopol’sky bulv., Moscow, 117638

A. Zabolotsky

Russian Research Center for Molecular Diagnostics and Therapy

Email: phaustova112@yandex.ru
Россия, 8 Simferopol’sky bulv., Moscow, 117638

O. Zhunina

Russian Research Center for Molecular Diagnostics and Therapy; N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: phaustova112@yandex.ru
Россия, 8 Simferopol’sky bulv., Moscow, 117638; 4 ul. Kosygina, Moscow, 119991

M. Fomicheva

Russian Research Center for Molecular Diagnostics and Therapy

Email: phaustova112@yandex.ru
Россия, 8 Simferopol’sky bulv., Moscow, 117638

V. Schvets

MIREA — Russian Technological University, Institute of Fine Chemical Technologies

Email: phaustova112@yandex.ru
Россия, 78 prosp. Vernadskogo, Moscow, 119454

A. Lobanov

N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: phaustova112@yandex.ru
Россия, 4 ul. Kosygina, Moscow, 119991

N. Yabbarov

Russian Research Center for Molecular Diagnostics and Therapy; N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: phaustova112@yandex.ru
Россия, 8 Simferopol’sky bulv., Moscow, 117638; 4 ul. Kosygina, Moscow, 119991

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2019

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).